The Complex Microbial Systems Group develops advanced measurements and standards for exploitation of microbes to promote human health, precision medicine, advanced manufacturing and other industrial applications. The group uses genomic and metagenomic approaches to improve measurements on microbiomes, and is developing reference materials for assessing the sensitivity and specificity of pathogen detection devices. Advanced methods including microfluidics, predictive modeling of engineered microbes, bioinformatics and state-of-the-art imaging are being applied to critical areas such as combatting antibiotic resistance, food safety, clinical diagnostics, and engineering biology.
Microbes have essential roles in nearly every ecological niche on Earth, including the human body. The NIST Microbiome Program supports the rapidly growing industries that are developing microbial-based solutions to treat disease, improve human and environmental health, enhance agricultural productivity and food safety, bioremediate waste, produce new biofuels, and avert infrastructure corrosion. Our efforts include:
In collaboration with partners and stakeholders, NIST develops standards, methods, and measurement solutions to support the advancement of clinical diagnostics, biothreat detection, recreational water quality monitoring, biomanufacturing quality control, wastewater surveillance, and spread of antimicrobial resistance. Specific projects include:
International Microbiome and Multi'omics Standards Alliance
Joint Agency Microbiome Alliance
Rapid Microbial Testing Methods
IMMSA 2022 Workshop (Boulder, CO)
2021 Standards to Support an Enduring Capability in Wastewater Surveillance for Public Health
2020 Measuring SARS-CoV-2 in Wastewater and Fecal Material: A Call for Standards
2019 NIST Workshop on Standards for Microbiome Measurements
2017 Standards for Pathogen Detection for Biosurveillance and Clinical Applications